Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -306,620 | -290,976 | -230,699 | -119,491 | -79,049 |
| Depreciation Amortization | 9,160 | 5,740 | 1,847 | 1,688 | 2,965 |
| Accounts receivable | -1,250 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -815 | 4,213 | -1,958 | 2,163 | 981 |
| Other Working Capital | 63,685 | -4,148 | 15,003 | 7,201 | -725 |
| Other Operating Activity | 55,081 | 49,545 | 36,035 | 20,937 | 15,803 |
| Operating Cash Flow | $-180,759 | $-235,626 | $-179,772 | $-87,502 | $-60,025 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -116,215 | 66,031 | -160,364 | 120,141 | 86,761 |
| PPE Investments | -4,513 | -5,572 | -35,925 | -20,232 | -3,020 |
| Investing Cash Flow | $-120,728 | $60,459 | $-196,289 | $99,909 | $83,741 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -389 | -486 | -528 | N/A | N/A |
| Common Stock Issued | 429,649 | 195,967 | 365,567 | 20,405 | 600 |
| Other Financing Activity | -1,686 | -6,695 | -7,503 | -357 | -94 |
| Financing Cash Flow | $427,574 | $188,786 | $357,536 | $20,048 | $506 |
| Beginning Cash Position | 75,711 | 62,092 | 80,617 | 48,162 | 23,940 |
| End Cash Position | 201,798 | 75,711 | 62,092 | 80,617 | 48,162 |
| Net Cash Flow | $126,087 | $13,619 | $-18,525 | $32,455 | $24,222 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180,759 | -235,626 | -179,772 | -87,502 | -60,025 |
| Capital Expenditure | -4,513 | -5,733 | -35,925 | -20,232 | -3,020 |
| Free Cash Flow | -185,272 | -241,359 | -215,697 | -107,734 | -63,045 |